Blood test may predict Crohn's drug success
NCT ID NCT03142321
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study aimed to find ways to predict whether the drug vedolizumab will help people with small bowel Crohn's disease. Researchers looked at blood markers and MRI scans in 48 adults to see if they could tell early on who would respond well. The goal is to help doctors choose the right treatment for each patient sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE OF SMALL INTESTINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.